Exact Sciences to participate in May investor conference

Exact Sciences Corp. (NASDAQ: EXAS) announced participation in the BofA Securities Healthcare Conference in Las Vegas on May 11, 2022, at 5:00 p.m. ET.

Rhea-AI Summary

Exact Sciences Corp. (NASDAQ: EXAS) announced participation in the BofA Securities Healthcare Conference in Las Vegas on May 11, 2022, at 5:00 p.m. ET. Investors can access the webcast via the investor relations section of Exact Sciences' website. The company is focused on cancer diagnostics, developing tests like Cologuard and Oncotype to support patients throughout their cancer journey. Exact Sciences aims to provide innovative solutions for cancer screening and diagnosis.

Argus Session date unavailable

+4.36% session move Open Argus

Details

News Market Reaction – EXAS

The recorded move for EXAS in the trading session of this news was +4.36%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MADISON, Wis., May 2, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced that company management will participate in the following conference and invited investors to participate by webcast.

• BofA Securities Healthcare Conference, Las Vegas
  Fireside Chat on Wednesday, May 11, 2022 at 5:00 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conference-301536912.html

SOURCE Exact Sciences Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Exact Sciences participate in the BofA Securities Healthcare Conference?

Exact Sciences will participate in the conference on May 11, 2022, at 5:00 p.m. ET.

How can investors access the Exact Sciences conference webcast?

Investors can access the webcast on Exact Sciences' investor relations website.

What is the main focus of Exact Sciences?

Exact Sciences specializes in cancer screening and diagnostic tests, including Cologuard and Oncotype.

Where is the BofA Securities Healthcare Conference taking place?

The BofA Securities Healthcare Conference is being held in Las Vegas.

What recent developments are highlighted in the Exact Sciences press release?

The press release highlights Exact Sciences' participation in an upcoming investor conference and its ongoing commitment to cancer diagnostics.